InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,864.67
(
0.40%
)
US TECH 100
19,783.20
(
0.68%
)
Dow Jones
43,275.91
(
0.09%
)
Brent Oil
72.94
(
0.00%
)
Bitcoin
68,167.54
(
-0.28%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Rentier

Send PM Follow Ignore
Followers 14
Posts 949
Boards Moderated 0
Alias Born 01/03/2013

Rentier

Re: None

Tuesday, 02/12/2013 9:53:15 AM

Tuesday, February 12, 2013 9:53:15 AM

Post# of 97239
ZIOP Phase 3 Trial of Palifosfamide in First-Line Metastatic Soft Tissue Sarcoma Reaches Target Number of Progression-Free Survival Events

http://www.4-traders.com/ZIOPHARM-ONCOLOGY-INC-33865/news/ZIOPHARM-Oncology-Inc-Phase-3-Trial-of-ZIOPHARM-S-Palifosfamide-in-First-Line-Metastatic-Soft-Tis-16044826/

up over 12% and over 1.6 million traded already.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up